The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets

Pancreatic cancer is a highly aggressive malignancy that features high recurrence rates and the poorest prognosis of all solid cancers. The urokinase plasminogen activation system (uPAS) is strongly implicated in the pathophysiology and clinical outcomes of patients with pancreatic ductal adenocarci...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Ashna A., Buckley, Benjamin J., Ranson, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961517/
https://www.ncbi.nlm.nih.gov/pubmed/35204653
http://dx.doi.org/10.3390/biom12020152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961517/
https://www.ncbi.nlm.nih.gov/pubmed/35204653
http://dx.doi.org/10.3390/biom12020152

Ejemplares similares